InsidersTradesSigma
Follow the Bicara Therapeutics Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.7bn. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Among the most active insiders: Cohlhepp Ryan. Every trade is accessible without an account.
82
Insider Decl.
n/a
Thresholds
€4m
1 ops.
Buy Volume
€4m
20 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bicara Therapeutics Inc. Buy (bullish), based on 13 analysts. Average price target: US$33.38.
48Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 August 2026
Declarations82 total
18,750 shares@ US$3.78980.0045% mcap1.9% of flowCommon StockSEC:0001470831-26-000812:0
18,750 shares@ US$27.97510.034% mcap14.3% of flowCommon StockSEC:0001470831-26-000812:1
10,000 shares@ US$3.78980.0024% mcap1.6% of flowCommon StockSEC:0001470831-26-000813:0
10,000 shares@ US$27.9750.018% mcap11.9% of flowCommon StockSEC:0001470831-26-000813:1
10,000 shares@ US$27.830.015% mcap13.7% of flowCommonSEC144:0001969223-26-000869
18,750 shares@ US$27.830.028% mcap16.9% of flowCommonSEC144:0001969223-26-000872
10,000 shares@ US$3.78980.0020% mcap2.2% of flowCommon StockSEC:0001470831-26-000714:0
9,972 shares@ US$28.41630.015% mcap16.3% of flowCommon StockSEC:0001470831-26-000714:1
28 shares@ US$29.680.0000% mcap0.0% of flowCommon StockSEC:0001470831-26-000714:2
10,000 shares@ US$29.680.016% mcap21.0% of flowCommonSEC144:0001969223-26-000775
18,750 shares@ US$3.78980.0038% mcap2.8% of flowCommon StockSEC:0001470831-26-000701:0
22,833 shares@ US$28.75890.035% mcap26.0% of flowCommon StockSEC:0001470831-26-000701:1
4,306 shares@ US$29.79610.0068% mcap5.1% of flowCommon StockSEC:0001470831-26-000701:2
1,075 shares@ US$30.35490.0017% mcap1.3% of flowCommon StockSEC:0001470831-26-000701:3
536 shares@ US$29.000.0008% mcap0.6% of flowCommon StockSEC:0001470831-26-000701:4
50,000 shares@ US$28.56160.075% mcap100.0% of flowCommonSEC144:0001950047-26-006962
28,750 shares@ US$30.250.046% mcap73.7% of flowCommonSEC144:0001969223-26-000773
25 of 82 declarations
关于 Bicara Therapeutics Inc.
Bicara Therapeutics Inc. 是一家生物制药公司，专注于开发创新的癌症治疗方法。它采用基于免疫疗法的方法来靶向肿瘤。